These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29072546)

  • 21. [A study on the coverage, strategy and cost of hepatitis B vaccination in China, 1996].
    Zeng X; Yang G; Liao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Oct; 19(5):277-81. PubMed ID: 10322686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis on sero-epidemiological characteristics of hepatitis B virus among people born during 1994-2001 before and after hepatitis B vaccine catch-up vaccination, China].
    Wang FZ; Zheng H; Miao N; Sun XJ; Zhang GM; Liang XF; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):469-474. PubMed ID: 28592087
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage?
    de la Hoz F; Perez L; Wheeler JG; de Neira M; Hall AJ
    Trop Med Int Health; 2005 Apr; 10(4):322-9. PubMed ID: 15807795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decomposing socioeconomic inequalities in depressive symptoms among the elderly in China.
    Xu Y; Yang J; Gao J; Zhou Z; Zhang T; Ren J; Li Y; Qian Y; Lai S; Chen G
    BMC Public Health; 2016 Dec; 16(1):1214. PubMed ID: 27905918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing hepatitis B though universal vaccination: reduction of inequalities through the GAVI China project.
    Cui F; Liang X; Gong X; Chen Y; Wang F; Zheng H; Wu Z; Miao N; Hadler SC; Hutin YJ; Luo H; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J29-35. PubMed ID: 24331017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
    J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students.
    Patrick DM; Bigham M; Ng H; White R; Tweed A; Skowronski DM
    Pediatr Infect Dis J; 2003 Oct; 22(10):874-7. PubMed ID: 14551487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

  • 31. Compliance with birth dose of Hepatitis B vaccine in high endemic and hard to reach areas in the Colombian amazon: results from a vaccination survey.
    Choconta-Piraquive LA; De la Hoz-Restrepo F; Sarmiento-Limas CA
    BMC Health Serv Res; 2016 Jul; 16():293. PubMed ID: 27443313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response in infants after universal high-dose hepatitis B vaccination: A community-based study in Beijing, China.
    Xiao M; Qiu Q; Pang X; Liang X; Li L; Cui F; Wang F; Zhang G; Li H; Wang L; Zhang W
    Vaccine; 2015 Oct; 33(43):5878-5883. PubMed ID: 26117148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination.
    Su FH; Cheng SH; Li CY; Chen JD; Hsiao CY; Chien CC; Yang YC; Hung HH; Chu FY
    Vaccine; 2007 Nov; 25(47):8085-90. PubMed ID: 17920732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of hepatitis B and factors potentially associated in a population-based study in Medellin, Colombia.
    Cadavid-Betancur DA; Ospina MC; Hincapié-Palacio D; Bernal-Restrepo LM; Buitrago-Giraldo S; Perez-Toro O; Santacruz-Sanmartín E; Lenis-Ballesteros V; Almanza-Payares R; Díaz FJ
    Vaccine; 2017 Sep; 35(37):4905-4912. PubMed ID: 28780978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.